SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure after Q3 results highlighted weaker trading activity, with headline profit largely driven by gains on crypto holdings; the Binance hack and broader crypto weakness added to selling pressure. Traders are split between viewing the decline as a buying opportunity and worrying that soft volumes and shaken confidence in exchanges could prolong the downturn.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as Middle East conflict, tanker and refinery attacks, and risks to Strait of Hormuz oil flows fuel concerns about disrupted supply and higher crude prices. Traders are split between bullish bets on continued escalation and bearish views that diplomacy or a ceasefire could unwind the geopolitical risk premium.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 AML trial reaching its 80-event milestone, which starts database lock, unblinding and final analysis, is drawing attention ahead of the expected topline results. Bulls point to the trials long duration and extended GPS dosing as possible signs of durable survival benefit, while skeptics question the dosing changes and trial design; the share-price decline has added to the debate.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

XBI is drawing attention as biotech swings sharply amid a broad sector pullback, with traders tracking its support levels and weighing whether weakness reflects higher-rate concerns and rotation back to AI and large-cap tech. Bulls see potential support from biotech dealmaking, clinical catalysts, and a possible rotation into the sector, while others remain cautious about the downturn continuing.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Cornings strong third-quarter results and upbeat outlook are drawing attention, led by AI-related optical communications growth, but shares are selling off despite the beat. Traders are debating whether broader AI-sector concerns, weak technicals and solar-related investment costs are outweighing the fundamentals.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Bank of America upgrade has put DraftKings prediction-market business in focus, with traders pointing to growing DKeX activity and potential fees as a new opportunity rather than only a threat from Kalshi and Polymarket. The community remains divided over whether that growth can translate into meaningful earnings amid regulatory uncertainty, sportsbook competition and scrutiny of betting rules; Q3 results are also approaching.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a 52-week high has focused attention on TGTX, with traders weighing BRIUMVIs sales momentum and Q3 results against anticipated subcutaneous BRIUMVI data. Buyout speculation and possible short covering are also prominent, but no acquisition is confirmed.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladocs quarterly report and stronger profitability and cash-flow outlook are driving attention, with traders also pointing to progress shifting BetterHelp toward insurance-funded care. Bulls see a turnaround and speculate about a short squeeze, while skeptics note declining revenue and continued weakness at BetterHelp.

Select Sector SPDR Trust (The) - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

XLP is drawing attention after rebounding from a technical support zone and pushing back toward recent highs, with traders watching whether it can hold around the 89 area. The move is also being discussed as part of a rotation into defensive staples amid tech weakness, though some traders warn the sectors rally may be stretched.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs planned move from the NYSE to Nasdaq and plans for hybrid three-row SUVs are drawing attention, with traders linking the announcements to the companys technology-focused repositioning and recent strength. The reaction is mixed: bullish traders point to the shift and buybacks, while skeptics question whether the companys strategy and cautious profit outlook justify the optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TPG RE Finance Trust (TRTX) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for TPG RE Finance Trust (TRTX) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

TPG RE Finance Trust (TRTX) Lags Q3 Earnings and Revenue Estimates

TPG RE Finance Trust (TRTX) delivered earnings and revenue surprises of -73.08% and -3.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

TPG RE Finance Trust, Inc. Reports Operating Results for the Quarter Ended September 30, 2026

TPG RE Finance Trust, Inc. (NYSE: TRTX) (TRTX or the Company) reported its operating results for the quarter ended September 30, 2026. Regarding third quarter results, Doug Bouquard, Chief Executive Officer of TRTX, said: Our third quarter results demonstrate TRTXs continued successful execution of...

TRTX vs. VTMX: Which Stock Is the Better Value Option?

Is TPG RE Finance Trust (TRTX) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

TPG RE Finance Trust, Inc. Announces Third Quarter 2026 Earnings Release and Conference Call Dates

TPG RE Finance Trust, Inc. (NYSE: TRTX) (TRTX or the Company) today announced it will release financial results for the third quarter 2026 and file its Form 10-Q and earnings supplemental after the market close on Monday, October 26, 2026. CONFERENCE CALL AND WEBCAST INFORMATION The Company will...

TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock

TPG RE Finance Trust, Inc. (NYSE: TRTX) (TRTX or the Company) today announced that the Companys Board of Directors has declared a cash dividend of $0.24 per share of common stock for the third quarter of 2026. The dividend will be payable on October 23, 2026 to common stockholders of record as of...

TPG RE Finance Trust, Inc. Announces Pricing of $1.0 Billion Commercial Real Estate CLO

TPG RE Finance Trust, Inc. (NYSE: TRTX) (TRTX or the Company) today announced the pricing of TRTX 2026-FL8, a $1.0 billion managed Commercial Real Estate Collateralized Loan Obligation. The Company expects approximately $820.0 million of investment grade securities to be placed with institutional...

TPG RE Finance Trust, Inc. Declares Cash Dividend on Series C Cumulative Redeemable Preferred Stock

TPG RE Finance Trust, Inc. (NYSE: TRTX) (TRTX or the Company) today announced the Companys Board of Directors declared a cash dividend of $0.3906 per share of 6.25% Series C Cumulative Redeemable Preferred Stock (the Series C Preferred Stock) for the third quarter of 2026. The Series C Preferred...

TPG RE Finance Trust (TRTX) Q2 Earnings and Revenues Miss Estimates

TPG RE Finance Trust (TRTX) delivered earnings and revenue surprises of -8.00% and -7.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

• Reported GAAP EPS of $0.07 down -72.00% YoY
• Reported revenue of $35.92M down -5.07% YoY

TPG RE Finance Trust's book value per common share was $10.85 versus $10.95; realized loan write-offs related to REO conversions were $13.01M; TRTX cited risks concerning investment performance and loan origination.

TPG RE Finance Trust originated and acquired loans with $772.7M in commitments, closed a $1B CRE CLO placing approximately $820M investment-grade securities, and authorized $50M in repurchases.

TPG RE Finance Trust, Inc. is a holding company, which engages in the provision of commercial real estate finance services. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments in North America. The company was founded on October 24, 2014 and is headquartered in New York, NY.

TPG RE Finance Trust Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$6.50
Prev Close	$6.42
Open	$6.46
Dividend Yield	11.15%
50-Day Moving Average	$6.78
Beta	0.79
Avg. Volume	995,864.53
PE Ratio	16.66

52-Week High	$9.35
52-Week Low	$5.60
Market Capitalization	$492.88M
EPS (Annual)	$0.5724
Price to Book	0.48
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

TRTX Fundamentals